We are live on
!
Find out more
EAM
EULAV Asset Management Portfolio holdings
AUM
$3.13B
1-Year Est. Return
23.04%
This Fund
S&P 500
This Quarter
Est. Return
-0.64%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$1.84B
AUM Growth
-$27.2M
(-1.5%)
Cap. Flow
+$4.14M
Cap. Flow
% of AUM
0.22%
Top 10 Holdings %
Top 10 Hldgs %
9.64%
Holding
397
New
18
Increased
106
Reduced
77
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$12M |
| 2 |
Delta Air Lines
DAL
|
+$8.03M |
| 3 |
Trimble
TRMB
|
+$7.8M |
| 4 |
MON
Monsanto Co
MON
|
+$7.72M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
+$7.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$5.07M |
| 2 |
SAP
SAP
|
+$4.61M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$4.14M |
| 4 |
Mastercard
MA
|
+$4.07M |
| 5 |
Oracle
ORCL
|
+$4.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 23.06% |
| 2 | Consumer Discretionary | 14.02% |
| 3 | Healthcare | 12.71% |
| 4 | Technology | 11.4% |
| 5 | Financials | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Lamar Advertising Co
LAMR
$16.3B
| $3.4M | 0.18% |
+69,000
| New | +$3.55M |
|
|
LLL
177
DELISTED
L3 Technologies, Inc.
LLL
| $3.38M | 0.18% |
28,400
| – | – |
|
|
AKRX
178
DELISTED
Akorn Inc
AKRX
| $3.36M | 0.18% |
92,600
| – | – |
|
179
Genuine Parts
GPC
$17.2B
| $3.33M | 0.18% |
38,000
| – | – |
|
180
Core Laboratories
CLB
$477M
| $3.32M | 0.18% |
22,700
| – | – |
|
|
PPLI
181
People Inc
PPLI
$3.08B
| $3.29M | 0.18% |
+279,770
| New | +$3.38M |
|
|
AXE
182
DELISTED
Anixter International Inc
AXE
| $3.29M | 0.18% |
38,800
-9,700
| -20% | -$881K |
|
|
DFS
183
DELISTED
Discover Financial Services
DFS
| $3.28M | 0.18% |
51,000
| – | – |
|
184
Medtronic
MDT
$110B
| $3.28M | 0.18% |
53,000
+25,000
| +89% | +$1.59M |
|
185
Intel
INTC
$460B
| $3.27M | 0.18% |
94,000
-35,000
| -27% | -$1.19M |
|
186
T. Rowe Price
TROW
$25.6B
| $3.25M | 0.18% |
41,400
-6,600
| -14% | -$530K |
|
187
Ziff Davis
ZD
$1.94B
| $3.24M | 0.18% |
75,555
+19,550
| +35% | +$867K |
|
188
Amazon
AMZN
$2.53T
| $3.22M | 0.18% |
200,000
+80,000
| +67% | +$1.33M |
|
|
DNB
189
DELISTED
Dun & Bradstreet
DNB
| $3.13M | 0.17% |
26,600
| – | – |
|
190
Toll Brothers
TOL
$14B
| $3.12M | 0.17% |
+100,000
| New | +$3.43M |
|
191
ExxonMobil
XOM
$651B
| $3.1M | 0.17% |
33,000
-26,000
| -44% | -$2.59M |
|
192
AT&T
T
$159B
| $3.1M | 0.17% |
116,512
| – | – |
|
193
Equifax
EFX
$20.7B
| $3.09M | 0.17% |
41,300
+1,000
| +2% | +$76.2K |
|
194
Prosperity Bancshares
PB
$8.97B
| $3.06M | 0.17% |
53,600
| – | – |
|
195
Boeing
BA
$175B
| $3.06M | 0.17% |
24,000
| – | – |
|
|
EMC
196
DELISTED
EMC CORPORATION
EMC
| $3.03M | 0.16% |
103,442
-85,000
| -45% | -$2.45M |
|
197
Equity Lifestyle Properties
ELS
$12.7B
| $2.96M | 0.16% |
140,000
| – | – |
|
198
Amgen
AMGN
$209B
| $2.95M | 0.16% |
21,000
+3,300
| +19% | +$431K |
|
199
Global Payments
GPN
$23.8B
| $2.95M | 0.16% |
84,400
| – | – |
|
200
Rush Enterprises Class A
RUSHA
$6.21B
| $2.93M | 0.16% |
197,325
+36,000
| +22% | +$565K |
|
Similar funds
LFG
BI
GKWIM
DIG
BP
CCI
PC
TCG
EULAV Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, EULAV Asset Management held 397 positions worth $1.84B, down 1.5% from $1.87B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
EULAV Asset Management's Q3 2014 filing shows 18 new, 106 increased, 77 reduced and 48 closed positions. Its largest new stake was Celgene Corp: 133,000 shares worth $12.6M. The largest sale was UnitedHealth, an estimated $5.07M.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- EULAV Asset Management's largest Q3 2014 buy was Celgene Corp: 133,000 shares worth $12.6M.
- EULAV Asset Management added most to Trimble in Q3 2014, an estimated $7.8M increase.
- EULAV Asset Management's biggest Q3 2014 reduction was Novo Nordisk, cutting an estimated $4.14M.
- EULAV Asset Management fully exited UnitedHealth in Q3 2014, selling an estimated $5.07M.
- EULAV Asset Management's ten largest holdings make up 9.6% of its $1.84B portfolio in Q3 2014.
- EULAV Asset Management opened 18 new positions and closed 48 in Q3 2014.
- EULAV Asset Management's portfolio value fell 1.5% quarter-over-quarter to $1.84B.
Based on EULAV Asset Management's 13F filing for Q3 2014, filed 17 Nov 2014.